Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Sale |
2025-03-13 4:13 pm |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
143 | $12.12 | $1,733 | 96,057 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 2:04 pm |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer |
1,482 | $22.82 | $33,819 | 148,518 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-04 Option Award |
2024-12-06 4:05 pm |
N/A 2034-12-03 |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
98,100 | $0 | 156,500 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-03 6:16 pm |
N/A 2034-09-02 |
Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer |
243,700 | $0 | 243,700 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:27 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer |
130,000 | $0 | 220,000 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-08 11:35 am |
N/A 2032-03-01 |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna Chief Business Officer, Global |
135,000 | $0 | 135,000 (Direct) |
View |